openPR Logo
Press release

Blood Cancer Drugs market Comprehensive Growth Analysis With Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin)

04-08-2019 08:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: marketstudyreport.com

Blood Cancer Drugs market Comprehensive Growth Analysis With

The ‘Blood Cancer Drugs market’ report published by Market Study Report, LLC, enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.

The global blood cancer drugs market is anticipated to reach USD 55.6 billion by 2025 according to a new report. The demand for blood cancer drug is primarily driven by growing death incidences by blood cancer, and continuous innovation for developing novel treatments with the help of several ongoing clinical trials. Moreover, increasing research and development of biological and targeted therapies as treatment will spur the blood cancer drugs market during the upcoming period. However, the high price of drugs and the stringent government policies will limit the growth of blood cancer drugs market during the forecast period.

Request a sample Report of Blood Cancer Drugs Market at: https://www.marketstudyreport.com/request-a-sample/1695081?utm_source=OPEN.com&utm_medium=DC

Key Findings from the study suggest blood cancer drugs in the market are much innovative and manufacturers are progressively concentrating on innovation of combination drugs. Companies are in a stage of development of new drugs in order to provide novel treatments for blood cancer. The immunotherapy segment is anticipated to grow at a high growth rate over the forecast period. The growth of this segment is primarily driven by increased awareness for its use as an alternative and effective treatment for blood cancer. North America is presumed to dominate the global blood cancer drugs market over the forecast period. Asia Pacific region which shows signs of high growth potential owing to the booming economies of India, and China.

The global blood cancer drugs market is segmented into blood cancer type, drugs and treatment approaches. On the basis of blood cancer type, the global blood cancer drugs market is segmented into leukemia, lymphoma and myeloma. The lymphoma segment is expected to drive the majority market of blood cancer drugs followed by leukemia. The global market of this segment is primarily driven by the increasing prevalence of lymphoma, and presence of effective treatments in the market. On the basis of drugs, the global blood cancer drugs market is further categorized into Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others. This continuous innovation for treating various sub-types of blood cancers has led to the development of novel types of treatments. For instance, the combination of Revlimid and Velcade has emerged as the preferential drugs in trials for treating multiple myeloma.

On the basis of treatment approaches the global blood cancer drugs market is further segmented into Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic. Due to availability of variety of chemotherapeutic agent in the market chemotherapeutic drugs are expected to hold the higher share in blood cancer drugs market. Moreover, their effectiveness for the treatment of blood cancer and increasing number of cancer patients globally has garnered more demand for chemotherapeutic drugs throughout the world.

Enquiry about Blood Cancer Drugs market report before Buying at: https://www.marketstudyreport.com/enquiry-before-buying/1695081?utm_source=OPEN.com&utm_medium=DC

Most of the blood cancers start in the bone marrow, where blood is produced. In blood cancer the growth of normal blood cells is dislodged by the uncontrollable growth of abnormal blood cells. These cancerous cells prevent the blood from performing many of its functions. Hence, the existing treatments of blood cancer are being the foundation for developing the new drugs. The steady flow of the blood cancer drugs has created opportunity for research and development in the existing market. For instance, Amgen Inc. received approval for BLINCYTO in July 2017, which is used in treating B-cell precursor Acute Lymphoblastic leukemia. Similarly, European blood cancer drugs market witnessed the approvals of Gazyvaro, by Roche AG that is used in treating advanced follicular lymphoma. Also, novel technologies like CAR-T are likely to be launched this year.

Geographically, the global blood cancer drugs market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America dominates the blood cancer drugs market which is followed by Europe and Asia Pacific. Favorable reimbursement policies, surge in R&D investments of various companies, as well as the increase in the number of blood cancer treatments are some of the major factors responsible for the growth of North America’s blood cancer drugs market. Moreover, Asia-Pacific region has been identified as the lucrative market for the for blood cancer drugs due to increasing awareness of the use of these drugs, increased healthcare expenditure, and rising per capita disposable income. These are some of the major factors which are influencing the growth of the blood cancer drugs in Asia-pacific region.

The leading companies operating in this industry include Johnson & Johnson Inc., Amgen Inc., Bayer AG., Pfizer, Inc., AbbVie Inc., Roche Holding AG., Celgene Corporation, AstraZeneca, Novartis AG, GlaxoSmithKline PLC, Merck & Co., Inc., and Eli Lily & Co. among others.

Purchase full report of Blood Cancer Drugs market at: https://www.marketstudyreport.com/securecheckout/paymenta/1695081?utm_source=OPEN.com&utm_medium=DC?msfpaycode=sumsf

Blood Cancer Drugs Market share by Major regions included:

United States
North America
Asia Pacific
Europe
Middle East & Africa

Table of Contents

1.Overview and Scope
1.1.Research goal & scope
1.2.Research assumptions
1.3.Research methodology
1.3.1.Primary data sources
1.3.2.Secondary data sources
1.4.Key take-away
1.5.Stakeholders

2.Executive Summary
2.1.Market definition
2.2.Market segmentation
3.Blood cancer drugs market Insights
3.1.Blood Cancer Drug – Industry snapshot
3.1.1.Leading Companies
3.1.2.Emerging Companies & Technologies Platform
3.1.3.Key Companies to Watch
3.2.Blood Cancer Drug - Ecosystem analysis
3.2.1.Disease overview
3.2.2.Commercial Landscape
3.2.3.Future Treatment Paradigm
3.3.Blood cancer drugs market Dynamics
3.3.1.Blood Cancer Drug – Market Forces
3.3.1.1.Blood cancer drugs market Driver Analysis
3.3.1.2.Blood cancer drugs market Restraint/Challenges analysis
3.3.1.3.Blood Cancer Market Opportunity Analysis
3.3.2.Industry analysis - Porter's five forces
3.3.2.1.Bargaining power of supplier
3.3.2.2.Bargaining power of buyer
3.3.2.3.Threat of substitute
3.3.2.4.Threat of new entrant
3.3.2.5.Degree of competition
3.3.3.Blood cancer drugs market PEST Analysis, 2017
3.3.4.Blood cancer drugs market Value Chain Analysis
3.3.5.Blood Cancer Drug Industry Trends
3.3.6.Competitive Ranking Analysis
4.Blood cancer drugs market Size and Forecast, 2017-2025 by Blood Cancer Type
4.1.Key Findings
4.2.Lymphoma
4.2.1.Hodgkin Lymphoma

About Us:

Read More Reports On: https://www.marketwatch.com/press-release/North-America-Induction-Sealing-Machine-Market-Size-Rising-New-Technologies-Research-Forecast-to-2024-2019-04-08

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC.
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blood Cancer Drugs market Comprehensive Growth Analysis With Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin) here

News-ID: 1693796 • Views: 273

More Releases from marketstudyreport.com

Clinical Laboratory Services Market By Regional Trend & Growth Forecast 2019-202 …
Market Study Report recently introduced new title on “Global Carbon Black Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2025. The Latin America breast pump market accounted for more than 12% revenue share in 2018 and is assessed to witness a significant CAGR by 2025. This is due to the development in healthcare facilities
Sleep Apnea Devices Market - Growth, Trends, and Forecast (2019 - 2025)
Market Study Report recently introduced new title on “2019-2025 Global Sleep Apnea Devices Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2025. Technological advancements in sleep apnea devices is a major market growth augmenting factor. Hypoglossal Nerve Stimulation (HNS), is a completely novel approach for treating obstructive sleep apnea. Moreover, growing alcohol intake in
What's driving the Structural Steel Market trends? ArcelorMittal, Tata Steel, Ni …
A detailed study on ‘Structural Steel market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
What's driving the Industrial IoT (IIoT) Market trends? Rockwell Automation, ABB …
A detailed study on ‘Industrial IoT (IIoT) Market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors

All 5 Releases


More Releases for Blood

Blood Donation Chair
Blood Donation Chair Size: 190 L * 92 W * 135 - 164 H cm Back plate, the angle of inclination of the leg plate. Height adjustment. The adjustments are all electrically controlled and easy to operate. This product comes with three LINAK motors Maximum load capacity: 240 kg Optional: CPR function, weighing function The marketplace was wholly developed by the Jiangsu Medwish Network Technology Co., Ltd., a private corporation based in Jiangsu,
Blood Group Typing Market Banks on Increasing Need for Blood, Blood Products, an …
The global blood group typing market is foreseen to garner a massive demand in the foreseeable future owing to certain factors such as the rising demand for blood and blood products. Nonetheless, the market growth could see an escalation on the back of other factors such as increasing prenatal testing which requires blood grouping, mounting count of road mishaps and trauma incidences requiring blood transfusion, and increasing application in forensic
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New
Blood Group Typing Market Banks on Increasing Need for Blood, Blood Products, an …
The global blood group typing market is foreseen to garner a massive demand in the foreseeable future owing to certain factors such as the rising demand for blood and blood products. Nonetheless, the market growth could see an escalation on the back of other factors such as increasing prenatal testing which requires blood grouping, mounting count of road mishaps and trauma incidences requiring blood transfusion, and increasing application in forensic
Blood Bank Market 2017
ReportsWeb.com has announced the addition of the “Global Blood Bank Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Blood Bank industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard